{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-037044","form_type":"8-K","ticker":"CCEL","cik":"0000862692","company_name":"CRYO CELL INTERNATIONAL INC","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.983724+00:00","generated_at":"2026-06-30T04:40:13.028541+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cryo-Cell Q2 fiscal 2021 revenue down 8% to $7.21M; net income rises to $1.17M","bullets":["Revenue $7.21M, down 8% from $7.87M; processing/storage fees $7.16M.","Net income $1.17M ($0.15 basic EPS) vs $953K ($0.13) a year ago; net income up 23%.","Cost of sales decreased 10% and SG&A decreased 12% year-over-year, offsetting revenue decline.","Recorded $432K decrease in fair value of contingent consideration liability from Cord:Use earn-out; $240K amortization on Duke University license."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-037044","json":"https://secwatch.observer/filing/0001564590-21-037044.json","markdown":"https://secwatch.observer/filing/0001564590-21-037044.md","text":"https://secwatch.observer/filing/0001564590-21-037044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/0001564590-21-037044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/ccel-8k_20210715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:40:13.028541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}